Clinical Trials Directory

Trials / Terminated

TerminatedNCT00308789

A Trial of Infant Flow Biphasic Nasal Continuous Airway Pressure (NCPAP) Versus Infant Flow NCPAP for the Facilitation of Extubation in Infants </= 1250 Grams

Infant Flow Biphasic NCPAP Versus Infant Flow NCPAP for the Facilitation of Successful Extubation in Infants </= 1250 Grams: A Randomized Controlled Trial

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
136 (actual)
Sponsor
Mount Sinai Hospital, Canada · Academic / Other
Sex
All
Age
6 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare two methods of delivering Nasal Continuous Airway Pressure (NCPAP): Biphasic Mode and a continuous mode, to see which is better in getting babies off the ventilator and decreasing lung damage.

Detailed description

Chronic lung disease (CLD) remains a significant problem among low birth weight infants with a reported incidence of up to 26% in infants \< 1500 grams. Nasal continuous positive airway pressure (NCPAP) has been demonstrated to provide effective non-invasive respiratory support for preterm infants. The use of NCPAP is associated with a decreased need for mechanical ventilation and may impact on the incidence of CLD. There are two types of NCPAP now available, a Biphasic mode which allows for cycling at two different levels of positive pressure and a continuous mode which allows only for one level of positive pressure. Comparisons: Biphasic NCPAP will be compared with continuous CPAP to see which better facilitates the extubation of preterm infants who weigh \</= 1250 grams at birth. The incidence of CLD, retinopathy of prematurity, sepsis, intraventricular haemorrhage, periventricular leucomalacia and necrotizing entercolitis will also be compared between the two groups.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiphasic Infant flow NCPAPBiphasic Nasal continuous positive airway pressure
PROCEDURECPAPContinuous positive airway pressure

Timeline

Start date
2006-04-01
Primary completion
2008-12-01
Completion
2009-12-01
First posted
2006-03-30
Last updated
2009-05-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00308789. Inclusion in this directory is not an endorsement.